Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-02-27

Clinical Trial Update: Drug-Drug Interaction Between THC and AEF0117 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the interaction between THC and AEF0117 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AEF0117
  • THC (tetrahydrocannabinol)

Snippet

Sponsor: Aelis Farma | Conditions: Cannabis Abuse | Phase 1 | Status: WITHDRAWN